Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Regulatory News (VAL)

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes
Get Live Data
0.185    0.00 (0.00%)
Bid:
0.18
Ask:
0.19
Spread: 0.01 (5.556%)
Market Cap: £1.37m
VAL Live PriceLast checked at - London Stock Exchange

Intraday ValiRx Share Chart

Total Voting Rights

31 Dec 2012 07:00

RNS Number : 4844U
ValiRx PLC
31 December 2012
 



31 December 2012

VALIRX PLC

("ValiRx" or the "Company")

 

Total Voting Rights

 

In accordance with the Financial Services Authority's Disclosure and Transparency Rules, the Company hereby announces that it has 1,711,184,409 ordinary shares of 0.1p each in issue, each share carrying the right to one vote. The Company does not hold any ordinary shares in treasury.

 

The above figure of 1,711,184,409 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Services Authority's Disclosure and Transparency Rules.

 

 

 

Enquires

ValiRx plc

Tel: +44 (0) 20 3008 4416

Dr Satu Vainikka

www.ValiRx.com

Nominated Adviser

Cairn Financial Advisers LLP

 

Tel:+44 (0) 20 7148 7900

Liam Murray / Avi Robinson

Broker

Hybridan LLP

 

Tel: +44 (0) 20 7947 4350

Claire Noyce / Deepak Reddy

Peckwater PR

Tel: +44 (0)7879 458 364

Tarquin Edwards

tarquin.edwards@peckwaterpr.co.uk

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVREALAPAASAFFF
Date   Source Headline
27th Jan 20117:00 amRNSIssue of Equity
26th Jan 201110:58 amRNSResult of General Meeting
11th Jan 20117:00 amRNSPublication of Circular and Notice of GM
2nd Dec 20107:00 amRNSUpdate - Eurostars Programme
1st Dec 20107:00 amRNSTotal Voting Rights
10th Nov 20107:00 amRNSIssue of equity and update
1st Nov 20104:12 pmRNSTotal Voting Rights
29th Oct 20103:16 pmRNSIssue of Equity
29th Oct 20103:15 pmRNSChange of Adviser
11th Oct 201010:51 amRNSCompletion of Disposal
30th Sep 20102:17 pmRNSHalf Yearly Report
23rd Sep 20107:00 amRNSDisposal
31st Aug 20107:00 amRNSTotal Voting Rights
16th Aug 20105:12 pmRNSIssue of Equity
12th Aug 20107:00 amRNSLicensing Deal with Cancer Research Technology
15th Jul 20107:00 amRNSHPV Test Starts Clinical Validation
30th Jun 201010:15 amRNSResult of AGM
17th Jun 20107:00 amRNSEurostars' GeneICE Programme - First Year Review
17th Jun 20107:00 amRNSGeneICE Update
24th May 20107:00 amRNSRe Agreement
30th Apr 20102:47 pmRNSTotal Voting Rights
21st Apr 20104:08 pmRNSIssue of Equity - Replacement
21st Apr 20103:14 pmRNSResult of General Meeting
1st Apr 20103:19 pmRNSProposed reorg of share capital & Gen Meeting
1st Apr 201010:06 amRNSIssue of Equity
1st Apr 201010:06 amRNSTrading Update
31st Mar 20107:00 amRNSTotal Voting Rights
17th Mar 20107:00 amRNSSales and Distribution Agreement
15th Mar 201011:07 amRNSValiRx announces good stability data for VAL201
9th Mar 20107:00 amRNSFunding and Partnership Agreement
5th Mar 20103:00 pmRNSIssue of Equity
26th Feb 20104:30 pmRNSTotal Voting Rights
16th Feb 20109:00 amRNSIssue of Equity
29th Jan 201010:10 amRNSTotal Voting Rights
19th Jan 20107:00 amRNSGeneICE Update
13th Jan 20107:56 amRNSIssue of Equity
31st Dec 20098:03 amRNSIssue of Equity
30th Dec 20091:57 pmRNSResult of General Meeting
22nd Dec 200912:19 pmRNSRegional Funding
11th Dec 20097:42 amRNS?3m Equity Purchase Agreement
4th Dec 200910:14 amRNSNotice of General Meeting
25th Nov 20097:00 amRNSTrading Update
28th Sep 20097:40 amRNSHalf Yearly Report
14th Sep 20097:00 amRNSNew Distribution Venture & Trading Platform Launch
29th Jul 20098:06 amRNSAustralian Patent Acceptance
3rd Jul 200910:57 amRNSResult of AGM
10th Jun 20091:35 pmRNSFinal Results
10th Jun 20098:50 amRNSAward for cancer therapeutics project
29th May 20097:00 amRNSPlacing Summary and Total Voting Rights
11th May 20097:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.